Labcorp (NYSE: LH), a leading global life sciences company, today announced the availability of the Pixel by Labcorp® COVID-19 PCR Test Home Collection Kit for small businesses, an initiative aimed at ...

The US Food and Drug Administration (FDA) on Tuesday granted an emergency use authorization (EUA) to LabCorp allowing it to test self-collected nasal swab samples from patients for coronavirus disease ...

The Labcorp At-Home COVID-19 Test Kit brings lab-grade PCR analysis to a simple nasal swab you collect yourself in your living room. This bestseller keeps Labcorp shares on the radar of health-focused ...

BURLINGTON, N.C. (WJZY) — North Carolina-based LabCorp announced Tuesday that it has received an Emergency Use Authorization from the U.S. Food and Drug Administration for at-home COVID-19 test kits.

March 5 (Reuters) - Diagnostics company Laboratory Corp of America Holdings said on Thursday it will make its coronavirus test available for ordering by healthcare providers from 6 p.m. ET, as the U.S ...

UNITED STATES - The Food and Drug Administration authorized the first diagnostic test with a home collection option for COVID-19 on Tuesday, according to a news release from the agency. The LabCorp ...

The FDA has granted emergency approval use for a coronavirus test that can be conducted by patients at their homes. The FDA re-issued emergency use approval for the Pixel by LabCorp COVID-19 home ...

U.S. Centers for Disease Control and Prevention (CDC) Director Robert Redfield said at a congressional hearing on Tuesday ...

The FDA announced the first tests for patients to collect samples at home. The FDA announced the first tests for patients to collect samples at home. The first diagnostic test with a home collection ...

Our editors independently selected these items because we think you will enjoy them and might like them at these prices. If you purchase something through our links, we may earn a commission. Pricing ...

LabCorp posted first-quarter results that were generally consistent with our expectations, and we’re holding steady in our fair value estimate, as nothing in the quarter prompted us to materially ...